Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Patents as proxies: NIH hubs of innovation

Nature Biotechnology volume 32, pages 536–537 (2014)Cite this article

Subjects

The rate of invention may be a valuable metric for identifying strategic R&D investments to enhance knowledge creation, translational value and economic potential from NIH-supported research.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Patent quantity and quality.

References

  1. Ehrlich, E. NIH's Role in Sustaining The US Economy, A 2011 Update. http://www.unitedformedicalresearch.com/wp-content/uploads/2012/07/NIHs-Role-in-Sustaining-the-US-Economy-2011.pdf (March 2012).

    Google Scholar 

  2. National Institutes of Health: Moving Research from the Bench to the Bedside. Hearing before the House Energy and Commerce Committee, Subcommittee on Health. United States House of Representatives. 108th Cong., 1st Sess. http://www.gpo.gov/fdsys/pkg/CHRG-108hhrg88429/html/CHRG-108hhrg88429.htm (10 July 2003). (Statement of Soderstrom, Yale University, on behalf of Association of University Technology Managers)

  3. Best Practices in Transforming Research into Innovation: Creative Approaches to the Bayh-Dole Act. Hearing before the House Committee on Science, Space, and Technology, Subcommittee on Technology and Innovation. United States House of Representatives. 112th Cong., 2nd Sess. https://science.house.gov/sites/republicans.science.house.gov/files/documents/hearings/HHRG-112-%20SY-WState-TSherer-20120619.pdf (2012). (Statement of Todd T. Sherer, PhD, CLP, Association of University Technology Managers).

  4. Families USA's Global Health Initiative. In Your Own Backyard: How NIH Funding Helps Your State's Economy http://archive-org.com/page/596772/2012-11-06/http://www.familiesusa.org/issues/global-health/publications/backyard-key-findings.html (2008).

  5. The Federation of American Societies for Experimental Biology has curated a comprehensive list of publications that assess the economic benefits of federally funded medical research. It can be viewed at http://www.faseb.org/Policy-and-Government-Affairs/Data-Compilations/Benefits-of-Biomedical-Research/Economic-Benefits.aspx

  6. Zeints, J.D. & Holdren, J.P. Memorandum for the Heads of Executive Departments and Agencies. M-12–15 (Washington, DC, June 2012). http://www.whitehouse.gov/sites/default/files/m-12-15.pdf

    Google Scholar 

  7. The White House. National Bioeconomy Blueprint (Washington, DC, 2012). http://www.whitehouse.gov/sites/default/files/microsites/ostp/national_bioeconomy_blueprint_april_2012.pdf

  8. Sarewitz, D. Nature 468, 135 (2010).

    Article  CAS  Google Scholar 

  9. Rothwell, J. et al. Patenting Prosperity: Invention and Economic Performance in the United State and its Metropolitan Areas (Brookings Institution; February 2013).

    Google Scholar 

  10. Hall, B.H., Jaffe, A. & Trajtenberg, M. Rand J. Econ. 36, 16–38 (2005).

    Google Scholar 

  11. Trajtenberg, M. Rand J. Econ. 21, 172–187 (1990).

    Article  Google Scholar 

  12. Harhoff, D. et al. Citation Frequency and the Value of Patented Innovation. Discussion Paper FS IV 97–26, (Wissenschaftszentrum Berlin, 1997).

    Google Scholar 

  13. Hall, B.H., Thoma, G. & Torrisi, S. The Market Value of Patents and R&D: Evidence from European Firms. Working Paper 13426 (National Bureau of Economic Research, Cambridge, MA, 2007).

    Book  Google Scholar 

  14. NIH RePORTER. http://projectreporter.nih.gov/reporter.cfm

  15. Reporting on utilization of subject inventions, 37 CFR 401.8 (2008).

  16. National Center for Advancing Translational Sciences (NCATS) was not included in this analysis, as many of National Center for Research Resource's research programs grants are now being administered by new institutes and centers and the core of NCATS, the Centers for Clinical and Translational Awards, have only been active since 2007.

  17. Harhoff, D. & Reitzig, M. Int. J. Ind. Organ. 22, 443–480 (2004).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Michael J. Kalutkiewicz is at the Academy of Radiology Research, Washington, DC, USA.,

    Michael J Kalutkiewicz

  2. Richard L. Ehman is at the Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.,

    Richard L Ehman

Authors
  1. Michael J Kalutkiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard L Ehman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J Kalutkiewicz.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kalutkiewicz, M., Ehman, R. Patents as proxies: NIH hubs of innovation. Nat Biotechnol 32, 536–537 (2014). https://doi.org/10.1038/nbt.2917

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2917

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research